Abstract
Two cases of malignant diffuse mesothelioma of the abdomen are presented. Both women demonstrated a prompt response to an oral alkylating agent, melphalan. The drug produced in both women a 22 and a 9 mo interval in which they were clinically free of disease. Multiple serial peritoneal fluid cytologic studies and biochemical evaluations using the sequential multiple analyzer (SMA 12–60) were carried out in the women. Cytogenetic analyses of peritoneal fluid was carried out in one woman during chemotherapy. These multiple serial peritoneal fluid studies indicated the disease-free state and allowed cessation of therapy and detected recurrent disease before clinical symptoms appeared. Monitoring of therapy for mesothelioma of the abdominal cavity in women is possible by serial peritoneal fluid study.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
